Korean Circ J.  1985 Sep;15(3):413-419. 10.4070/kcj.1985.15.3.413.

Effect of KCI Continus Tablet(K-Contin(R)) on Serum K and Uric Acid Level during Hydrochlorotihiazide Therapy

• Seo JD
• Ryu WS
• Oh BH
• Lee YW

• KMID: 1668691
• DOI: http://doi.org/10.4070/kcj.1985.15.3.413

Abstract

The effects of KCI continus tablet(K-Contin(R)) on the serum level of K and uric acid during hydrochlorothizide therapy(25mg/day) were evaluated in 30 patients with essential hypertensien. The results are as follows : 1) During hydrochlorothiazide therapy(25mg/day), 23% of all patients showed hypopotassemia(<3.5mEq/1) while no patient developed hypopotassemia after potassium supplement therapy(8 mEq/day). 2) During the period of K supplement, the level of serum uric acid showed less elevation. 3) The side reaction of KCI continus tablet were mild indigestion which developed in two patients and disappeared soon without any particular treatment. In conclusion, the KCI continus tablet is useful in the prevention of hypopotassemia during chronic diuretic therapy.

MeSH Terms

Dyspepsia
Humans
Hydrochlorothiazide
Hypokalemia
Potassium
Uric Acid*
Hydrochlorothiazide
Potassium
Uric Acid